OABI OmniAb
- 4.570
- +0.090+2.01%
OmniAb News
Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Green Thumb Industries (OtherGTBIF) and OmniAb (OABI)
OmniAb, Inc. (NASDAQ:OABI) Q1 2024 Earnings Call Transcript
RBC Capital Reaffirms Their Buy Rating on OmniAb (OABI)
Analysts Offer Insights on Healthcare Companies: ALX Oncology Holdings (ALXO), Lantern Pharma (LTRN) and OmniAb (OABI)
10-Q: Quarterly report
Earnings Flash (OABI) OMNIAB Reports Q1 Revenue $3.8M, Vs. Street Est of $5.9M
04:32 PM EDT, 05/09/2024 (MT Newswires) -- Earnings Flash (OABI) OMNIAB Reports Q1 Revenue $3.8M, vs. Street Est of $5.9M
OmniAb Q1 2024 GAAP EPS $(0.19) Misses $(0.16) Estimate, Sales $3.801M Miss $5.868M Estimate
OmniAb (NASDAQ:OABI) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.16) by 18.75 percent. This is a 216.67 percent decrease over losses of $(0.06) pe
Press Release: OmniAb Reports First Quarter 2024 Financial Results and Business Highlights
OmniAb Reports First Quarter 2024 Financial Results and Business Highlights Conference Call with Slides Begins at 4:30 p.m. Eastern Time Today EMERYVILLE, Calif.--(BUSINESS WIRE)--May 09, 2024-- Om
OmniAb (OABI) Receives a Buy From Craig-Hallum
OmniAb to Participate in Five Investor Conferences in May
EMERYVILLE, Calif.--(BUSINESS WIRE)--OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in five investor conferences during the month of May. RBC Capital Markets Global
OmniAb to Report First Quarter 2024 Financial Results on May 9
EMERYVILLE, Calif.--(BUSINESS WIRE)--OmniAb, Inc. (NASDAQ: OABI) will report financial results for the three months ended March 31, 2024 after the close of the U.S. financial markets on Thursday, May
RBC Capital Remains a Buy on OmniAb (OABI)
OmniAb Is Maintained at Buy by Truist Securities
OmniAb Is Maintained at Buy by Truist Securities
Truist Securities Maintains Buy on OmniAb, Maintains $10 Price Target
Truist Securities analyst Robyn Karnauskas maintains OmniAb (NASDAQ:OABI) with a Buy and maintains $10 price target.
Over $1M Bet On OmniAb? Check Out These 3 Stocks Insiders Are Buying
Although U.S. stocks closed lower on Monday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stoc
President of OmniAb Matthew Foehr Buys 8.4% More Shares
Those following along with OmniAb, Inc. (NASDAQ:OABI) will no doubt be intrigued by the recent purchase of shares by Matthew Foehr, President of the company, who spent a stonking US$1.2m on stock at a
OmniAb Inc (OABI) President and CEO Matthew Foehr Acquires 225,000 Shares
Craig-Hallum Sticks to Their Buy Rating for OmniAb (OABI)
OmniAb Insider Bought Shares Worth $1,167,750, According to a Recent SEC Filing
Matthew W Foehr, Director, President and CEO, on March 22, 2024, executed a purchase for 225,000 shares in OmniAb (OABI) for $1,167,750. Following the Form 4 filing with the SEC, Foehr has control ove
OmniAb(OABI.US) Officer Buys US$1.17 Million in Common Stocks
$OmniAb(OABI.US)$ Officer FOEHR MATTHEW W purchased 225K shares of Common Stocks on Mar 22, 2024 at an average price of $5.19 for a total value of $1.17 million.Source: Announcement What is statement
Analysis
Price Target
No Data
